Susanne Madden is founder and CEO of The Verden Group, a consulting firm founded to help practices navigate through the increasingly complex business of healthcare. Her career has spanned across several sections of the healthcare industry. Prior to founding Verden, she was employed by UnitedHealthcare in the area of physician network management and spent several years as an independent healthcare consultant specializing in business development, revenue cycle remediation, vendor management and process improvement.
Formerly a pediatric practice administrator and surgical practice billing manager, she understands the many different challenges facing practices today. With an MBA in both Management Systems and Information & Communication Systems, she has applied her formal learning to understanding the principles of knowledge management and how information can be transformed into comprehension at all levels with the right facilitation.
The Verden Group is the culmination of that knowledge, which seeks to inform, transform and reform the business of healthcare today.
Susanne writes frequently and speaks regularly on the business aspects of healthcare and is frequently quoted in industry and media publications.
A new study shows that a single dose of the Johnson and Johnson COVID-19 vaccine is less effective against Delta. Read more about it here.
"According to a new study which has not yet been peer-reviewed, patients who received the single-dose vaccine showed antibodies with low neutralizing titer compared to the modest neutralization titers found in those who received Pfizer and Moderna’s two-jab regimens. Patients who received the one-shot vaccine may be served by receiving a second dose, ideally one of the two mRNA vaccines."
Have you done a financial well checkup for your pediatric practice? Read PCC's blog on the critical areas to focus on.
"Auditing what services your practice offers and its revenue opportunities provides a clear starting point to begin examining your practice’s pricing. In 2021, the definition of RVUs and their value for E&M codes were changed. One of the fundamental changes that pediatricians haven’t yet grasped is that the RVUs of E&Ms has increased so much that it has lowered revenue in other specialties. By not updating your prices to reflect 2021 RVU values for E&Ms, your practice will be leaving money on the table when insurance payors flip to the new valuing system."